Eyepoint Pharmaceuticals Inc (EYPT) — Free Cash Flow Generation Index
Eyepoint Pharmaceuticals Inc (EYPT) has a Free Cash Flow Generation Index of 0.99x as of June 2023. Free cash flow of $56.63 Million represents 1% of operating cash flow ($57.02 Million). Read total liabilities of Eyepoint Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eyepoint Pharmaceuticals Inc Free Cash Flow Generation Index (2010–2023)
Historical FCF Generation Index trend for Eyepoint Pharmaceuticals Inc across 3 annual periods. Explore EYPT capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Eyepoint Pharmaceuticals Inc (2010–2023)
Year-by-year Free Cash Flow Generation Index for Eyepoint Pharmaceuticals Inc. For the full company profile including market capitalisation, see Eyepoint Pharmaceuticals Inc market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.86x | $-1.61 Million | $1.88 Million | $3.48 Million | ▼ -187.1% |
| 2015 | 0.98x | $10.14 Million | $10.30 Million | $161.00K | ▼ -1.4% |
| 2010 | 1.00x | $9.88 Million | $9.90 Million | $15.00K | — |